XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Shareholder's Equity (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Deficit
Retained Deficit
Cumulative Effect, Period of Adoption, Adjustment
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020 $ 507.5     $ 843.4   $ (363.4)   $ (12.9) $ 40.4
Beginning balance (in shares) at Dec. 31, 2020     45,164,308            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 9.8         9.8      
Other comprehensive income (loss) (1.4)               (1.4)
Stock-based compensation expense 1.8     1.8          
Stock option activity 2.5     2.5          
Issuance of treasury shares       (12.4)       12.4  
Issuance of treasury shares (in shares)     580,248            
Shares surrendered for taxes (0.5)             (0.5)  
Shares surrendered for taxes (in shares)     (72,174)            
Ending balance at Mar. 31, 2021 513.3 $ (6.4)   824.7 $ (10.6) (349.4) $ 4.2 (1.0) 39.0
Ending balance (in shares) at Mar. 31, 2021     45,672,382            
Beginning balance at Dec. 31, 2020 507.5     843.4   (363.4)   (12.9) 40.4
Beginning balance (in shares) at Dec. 31, 2020     45,164,308            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 63.8                
Other comprehensive income (loss) (2.5)                
Ending balance at Jun. 30, 2021 570.0     827.5   (295.4)     37.9
Ending balance (in shares) at Jun. 30, 2021     46,088,954            
Beginning balance at Mar. 31, 2021 513.3 $ (6.4)   824.7 $ (10.6) (349.4) $ 4.2 (1.0) 39.0
Beginning balance (in shares) at Mar. 31, 2021     45,672,382            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 54.0         54.0      
Other comprehensive income (loss) (1.1)               (1.1)
Stock-based compensation expense 1.8     1.8          
Stock-based compensation expense (in shares)     178,886            
Stock option activity 0.7     0.7          
Stock option activity (in shares)     66,615            
Issuance of treasury shares       (1.0)       1.0  
Issuance of treasury shares (in shares)     57,845            
Convertible notes settlement (in shares)     113,226            
Convertible notes settlement 1.3     1.3          
Ending balance at Jun. 30, 2021 570.0     827.5   (295.4)     37.9
Ending balance (in shares) at Jun. 30, 2021     46,088,954            
Beginning balance at Dec. 31, 2021 664.6     832.1   (188.2)     20.7
Beginning balance (in shares) at Dec. 31, 2021     46,268,855            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 37.1         37.1      
Other comprehensive income (loss) (1.9)               (1.9)
Stock-based compensation expense 2.1     2.1          
Stock-based compensation expense (in shares)     298,648            
Stock option activity 6.3     6.3          
Stock option activity (in shares)     406,750            
Purchase of treasury shares (3.4)             (3.4)  
Purchase of treasury shares (in Shares)     (169,816)            
Shares surrendered for taxes (1.6)     (0.2)       (1.4)  
Shares surrendered for taxes (in shares)     (91,853)            
Ending balance at Mar. 31, 2022 703.2     840.3   (151.1)   (4.8) 18.8
Ending balance (in shares) at Mar. 31, 2022     46,712,584            
Beginning balance at Dec. 31, 2021 664.6     832.1   (188.2)     20.7
Beginning balance (in shares) at Dec. 31, 2021     46,268,855            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 111.6                
Other comprehensive income (loss) (5.0)                
Ending balance at Jun. 30, 2022 768.9     843.9   (76.6)   (14.1) 15.7
Ending balance (in shares) at Jun. 30, 2022     46,411,393            
Beginning balance at Mar. 31, 2022 703.2     840.3   (151.1)   (4.8) 18.8
Beginning balance (in shares) at Mar. 31, 2022     46,712,584            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 74.5         74.5      
Other comprehensive income (loss) (3.1)               (3.1)
Stock-based compensation expense 2.2     2.2          
Stock-based compensation expense (in shares)     44,157            
Stock option activity 1.5     1.5          
Stock option activity (in shares)     92,290            
Purchase of treasury shares (9.3)             (9.3)  
Purchase of treasury shares (in Shares)     (437,638)            
Issuance of treasury shares       (0.1)       0.1  
Issuance of treasury shares (in shares)     2,285            
Shares surrendered for taxes (0.1)             (0.1)  
Shares surrendered for taxes (in shares)     (2,285)            
Ending balance at Jun. 30, 2022 $ 768.9     $ 843.9   $ (76.6)   $ (14.1) $ 15.7
Ending balance (in shares) at Jun. 30, 2022     46,411,393